Literature DB >> 4546711

A plasma factor inhibiting lymphocyte reactivity in urologic cancer patients.

A P McLaughlin, J D Brooks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4546711     DOI： 10.1016/s0022-5347(17)59733-5

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  4 in total

1.  Lymphocyte subsets in urologic cancer patients.

Authors:  M Shaw; P Ray; M Rubenstein; P Guinan
Journal:  Urol Res       Date:  1987

2.  Significance of tumour mass on T-lymphocyte levels in patients with gastrointestinal cancer.

Authors:  H S Shukla; R H Whitehead; L E Hughes
Journal:  Gut       Date:  1979-08       Impact factor: 23.059

3.  Study of nonspecific lymphocyte transformation in urologic cancer patients.

Authors:  I Romics; J Horváth
Journal:  Int Urol Nephrol       Date:  1978       Impact factor: 2.370

4.  Lymphocyte transformation in cancer patients: variation in results according to technique.

Authors:  G M Gyte; S M Watkins
Journal:  J Clin Pathol       Date:  1978-02       Impact factor: 3.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.